Look inside

Clinical Handbook of Psychotropic Drugs

Edited by: Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, J. Joel Jeffries

Print edition

In stock

US $99.80
Excluding tax

eBook

US $79.99
Excluding tax

Quick and comprehensive information on psychotropic drugs for adults.

  • Accurate and up-to-date - now with esketamine (Spravato)
  • Comparison charts help decision-making
  • Icons and full color
  • Available in print and online
  • Downloadable patient info sheets

More about this book

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

  • Independent, unbiased, up-to-date
  • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
  • Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug
  • Potential interactions and side effects summarized in comparison charts
  • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
  • Clearly written patient information sheets available for download as printable PDF files

New in this edition

  • Antidepressants chapter includes new section on esketamine (Spravato), recently approved for treatment-resistant depression; also updates to antidepressant use in pregnancy and SPARI drug interactions
  • Antipsychotics updates include new section on 5-HT2A inverse agonist antipsychotic (pimavanserin, Nuplazid) and comprehensive revision of augmentation strategies
  • Pharmacogenomics chapter fully revised with expanded dose adjustment recommendations
  • Chart of agents under investigation for treatment of substance use disorders fully revised, new agents include lofexidine (Lucemyra), Kadian, nortriptyline e-cigarettes
  • Unapproved treatments chapter with significant updates, including new sections on adrenergic agents in PTSD (doxazosin), antiflammatory agents in depression (pioglitazone, rosiglitazone, statins), and hormones in schizophrenia (raloxifene)
  • Expanded treatment options for extrapyramidal side effects include deutetrabenazine and valbenazine
  • New formulations and trade names include: Spravato (esketamine), as well as Adzenys ER, Aristada, Austedo, Cotempla XR-ODT, Fanatrex FusePaq, Foquest, Ingrezza, Jornay PM, Mydayis, Nuplazid, Sublocade, Zelapar

This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

To the CHPD Patient Information Sheets


Praise for the previous edition:

"As a psychiatrist who routinely prescribes medications, I find this handbook invaluable. It is the most comprehensive book on this topic that I have come across."
Corey Goldstein, MD, Rush University Medical Center

“A powerhouse of practical information... Unrivalled in scope... This outstanding and unique handbook is as rich in useful content as many full textbooks.”
Barbara Jovaisas, PharmD, in Canadian Pharmacists Journal

“Comprehensive… clearly organized… an ideal resource for rapid and straight-forward retrieval of essential clinical information… a ‘must have’ for those who work in mental health care.”
Marshall Cates, PharmD, in Annals of Pharmacotherapy

“Should be available at all nursing stations.”
C. Lindsay DeVane, PharmD, in American Journal of Health Systems Pharmacy

“The handbook is easy to use, comprehensive in scope, and up to date – a winner!"
Catherine Chiles, MD, in the Journal of Clinical Psychiatry

Available products of the Clinical Handbook of Psychotropic Drugs

Ref-ID: 600561